Clark R S, English M, McNeill G P, Newton R W
Br Med J (Clin Res Ed). 1985 Aug 3;291(6491):303-5. doi: 10.1136/bmj.291.6491.303.
Diabetes mellitus is associated with a high mortality after myocardial infarction. To see whether this may be decreased by improved diabetic control the effect of an insulin infusion regimen was studied in patients with acute myocardial infarction. From April 1982 to April 1983, 33 diabetics were admitted with acute myocardial infarction. Those being treated with diet alone or oral hypoglycaemic drugs continued with this unless control was poor, when they were changed to a "sliding scale" regimen of subcutaneous insulin injections thrice daily. Those already receiving insulin were maintained on thrice daily subcutaneous injections. From April 1983 to April 1984, 29 diabetics had acute myocardial infarction. Those receiving treatment with oral hypoglycaemic drugs or insulin were changed to continuous intravenous infusion of insulin, the aim being to maintain the blood glucose concentration at 4-7 mmol/I (72-126 mg/100 ml). Those being treated with diet alone continued with this if blood glucose concentrations were acceptable. Total mortality fell from 42% in the first year to 17% in the second (p less than 0.05). Over the same period mortality among non-diabetic patients with myocardial infarction did not change significantly. There was a significant fall in cardiac arrhythmias (expressed as the percentage of patients in whom arrhythmias were recorded) from 42% to 17% (p less than 0.05). The most significant fall in the incidence of complications occurred in those who had been receiving oral hypoglycaemic drugs on entry to the study (87% to 50%, p less than 0.05).
糖尿病与心肌梗死后的高死亡率相关。为了探究改善糖尿病控制是否可以降低死亡率,研究人员对急性心肌梗死患者采用胰岛素输注方案进行了研究。1982年4月至1983年4月,33名糖尿病患者因急性心肌梗死入院。那些仅接受饮食治疗或口服降糖药治疗的患者,除非血糖控制不佳,否则继续原治疗方案,若控制不佳则改为每日三次皮下注射胰岛素的“滑动剂量”方案。那些已经接受胰岛素治疗的患者继续每日三次皮下注射。1983年4月至1984年4月,29名糖尿病患者发生急性心肌梗死。那些接受口服降糖药或胰岛素治疗的患者改为持续静脉输注胰岛素,目标是将血糖浓度维持在4 - 7 mmol/L(72 - 126 mg/100 ml)。那些仅接受饮食治疗的患者,如果血糖浓度可接受则继续原方案。总死亡率从第一年的42%降至第二年的17%(p < 0.05)。同期,非糖尿病心肌梗死患者的死亡率无显著变化。心律失常发生率(以记录到心律失常的患者百分比表示)从42%显著降至17%(p < 0.05)。并发症发生率下降最显著的是那些在进入研究时接受口服降糖药治疗的患者(从87%降至50%,p < 0.05)。